Clinical Trials Directory

Trials / Completed

CompletedNCT00108368

The Effects of Risperidone and Olanzapine on Thinking

The Cognitive Effects of Risperidone and Olanzapine

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
Sponsor
US Department of Veterans Affairs · Federal
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The goal of this research is to find ways to maximize the benefits of antipsychotic medications for cognition. Hypothesis: Risperidone and olanzapine will show greater benefits than conventional medications on assessments of social cognition, particularly affect perception and social perception.

Conditions

Interventions

TypeNameDescription
DRUGRisperidone
DRUGOlanzapine

Timeline

Start date
2003-10-01
Completion
2006-03-01
First posted
2005-04-15
Last updated
2009-01-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00108368. Inclusion in this directory is not an endorsement.